JPH0129774B2 - - Google Patents
Info
- Publication number
- JPH0129774B2 JPH0129774B2 JP54007308A JP730879A JPH0129774B2 JP H0129774 B2 JPH0129774 B2 JP H0129774B2 JP 54007308 A JP54007308 A JP 54007308A JP 730879 A JP730879 A JP 730879A JP H0129774 B2 JPH0129774 B2 JP H0129774B2
- Authority
- JP
- Japan
- Prior art keywords
- solution
- prolamins
- occlusion
- prolamin
- physiologically compatible
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
- A61K49/0452—Solutions, e.g. for injection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Botany (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2803869A DE2803869C2 (de) | 1978-01-30 | 1978-01-30 | Injizierbare Embolisations- und Okklusionslösung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS54123281A JPS54123281A (en) | 1979-09-25 |
| JPH0129774B2 true JPH0129774B2 (2) | 1989-06-14 |
Family
ID=6030689
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP730879A Granted JPS54123281A (en) | 1978-01-30 | 1979-01-26 | Embolus that can be injected and blockade solution |
Country Status (8)
| Country | Link |
|---|---|
| JP (1) | JPS54123281A (2) |
| AT (1) | AT363599B (2) |
| AU (1) | AU525929B2 (2) |
| CA (1) | CA1116088A (2) |
| DE (1) | DE2803869C2 (2) |
| FR (1) | FR2415464A1 (2) |
| GB (1) | GB2014043B (2) |
| NL (1) | NL191433C (2) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107935870A (zh) * | 2017-11-09 | 2018-04-20 | 华中药业股份有限公司 | 一种2‑甲氨基‑5‑氯二苯甲酮的合成方法 |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3374659D1 (en) * | 1983-02-03 | 1988-01-07 | Ethicon Inc | Paste for hemostasis and for temporary relief of defects in the traumatism of bones |
| EP0128578A1 (de) * | 1983-06-14 | 1984-12-19 | Byk Gulden Lomberg Chemische Fabrik GmbH | Ethanolische Kontrastmittelsuspensionen |
| CA1225585A (en) * | 1983-06-30 | 1987-08-18 | Maria T. Litvinova | Composition for embolization of blood vessels |
| US4680171A (en) * | 1985-03-15 | 1987-07-14 | William Shell | Visualization of a bloodstream circulation with biodegradable microspheres |
| DE19608278A1 (de) * | 1996-02-23 | 1997-08-28 | Schering Ag | Pharmazeutische Mittel enthaltend perfluoralkylhaltige Metallkomplexe, und ihre Verwendung in der Tumortherapie und interventioniellen Radiologie |
| US6180113B1 (en) | 1996-02-23 | 2001-01-30 | Schering Ag | Pharmaceutical agents that contain perfluoroalkyl-containing metal complexes |
| KR970069028A (ko) * | 1996-04-01 | 1997-11-07 | 김은영 | 화학색전용 에멀젼의 제조방법 |
| US6333020B1 (en) | 1999-05-13 | 2001-12-25 | Micro Therapeutics, Inc. | Methods for treating AVM's using radio active compositions |
| DE10261694A1 (de) * | 2002-12-30 | 2004-07-15 | Brassel, Friedhelm, Prof. Dr.med. | Flüssiges Embolisat |
| CH712511B1 (de) * | 2006-09-18 | 2017-11-30 | Forim-X Ag C/O Prof Dr Med Richard Dirnhofer | Röntgenkontrastmittel für die postmortale, experimentelle und diagnostische Angiographie. |
| EP2063916B1 (de) * | 2006-09-18 | 2014-11-19 | Forim-X AG | Röntgenkontrastmittel für die postmortale, experimentelle und diagnostische angiographie |
| CN113813392A (zh) * | 2021-10-23 | 2021-12-21 | 哈尔滨工业大学 | 一种仿血细胞药物载体的制备方法 |
| CN118767106A (zh) * | 2024-06-12 | 2024-10-15 | 四川省医学科学院·四川省人民医院 | 玉米蛋白作为栓塞剂的应用、玉米蛋白栓塞系统与玉米蛋白复合药物栓塞系统及在制备经导管动脉化疗栓塞药物中的应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB311382A (en) * | 1928-05-10 | 1930-08-07 | H A Metz Lab Inc | Improvements in or relating to the manufacture of spinal anaesthetic solutions |
| CA958642A (en) * | 1969-06-11 | 1974-12-03 | Milos Sovak | Contrast media for radiography |
-
1978
- 1978-01-30 DE DE2803869A patent/DE2803869C2/de not_active Expired
-
1979
- 1979-01-17 AU AU43430/79A patent/AU525929B2/en not_active Ceased
- 1979-01-26 NL NL7900649A patent/NL191433C/xx not_active IP Right Cessation
- 1979-01-26 JP JP730879A patent/JPS54123281A/ja active Granted
- 1979-01-29 AT AT0065679A patent/AT363599B/de not_active IP Right Cessation
- 1979-01-29 GB GB7903005A patent/GB2014043B/en not_active Expired
- 1979-01-29 CA CA320,450A patent/CA1116088A/en not_active Expired
- 1979-01-29 FR FR7902217A patent/FR2415464A1/fr active Granted
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107935870A (zh) * | 2017-11-09 | 2018-04-20 | 华中药业股份有限公司 | 一种2‑甲氨基‑5‑氯二苯甲酮的合成方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| ATA65679A (de) | 1981-01-15 |
| DE2803869A1 (de) | 1979-08-02 |
| GB2014043B (en) | 1982-08-11 |
| DE2803869C2 (de) | 1983-12-29 |
| NL191433B (nl) | 1995-03-01 |
| NL191433C (nl) | 1995-07-04 |
| CA1116088A (en) | 1982-01-12 |
| FR2415464B1 (2) | 1983-07-01 |
| AT363599B (de) | 1981-08-10 |
| NL7900649A (nl) | 1979-08-01 |
| AU4343079A (en) | 1979-08-09 |
| GB2014043A (en) | 1979-08-22 |
| AU525929B2 (en) | 1982-12-09 |
| JPS54123281A (en) | 1979-09-25 |
| FR2415464A1 (fr) | 1979-08-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4268495A (en) | Injectable embolization and occlusion solution | |
| JP6893074B2 (ja) | 生体組織損傷の修復又は止血に用いる試薬及びその応用 | |
| JP7012779B2 (ja) | 精製された両親媒性ペプチド組成物を用いた、外科的方法 | |
| KR910005886B1 (ko) | 연골조직의 치료약제 | |
| US20070031467A1 (en) | Composition and method for vascular embolization | |
| JP2007514792A (ja) | 改良化血管欠損部閉鎖の組成物および方法 | |
| JPH0129774B2 (2) | ||
| US20060105014A1 (en) | Compositions, systems and methods for treatment of defects in blood vessels | |
| JP2010521495A5 (2) | ||
| JPS63281660A (ja) | 塞栓形成用組成物およびその用途 | |
| HRP20040486A2 (en) | Controlled release polymeric compositions of bone growth promoting compounds | |
| Becker et al. | Calcium alginate gel as a biocompatible material for endovascular arteriovenous malformation embolization: six-month results in an animal model | |
| JP2010083788A (ja) | 架橋ゼラチン、塞栓剤および架橋ゼラチンの製造方法 | |
| JP2002060341A (ja) | 止血剤 | |
| EP2353624A1 (en) | Embolic material, its process of preparation and its therapeutical uses thereof | |
| US20070031468A1 (en) | Modified chitosan for vascular embolization | |
| CN115335035A (zh) | 用于恢复和再生组织的生物填充物 | |
| EP2523700B1 (de) | Zusammensetzung zur erzeugung einer temporären darmokklusion | |
| RU2394574C1 (ru) | Способ коррекции ишемического поражения печени | |
| Strömberg et al. | An experimental study of autologous digital tendon transplants in the horse | |
| JPH07503001A (ja) | コラーゲンマイクロカプセル含有注射可能組成物 | |
| JP2003523319A (ja) | 閉塞した生物学的管を開通するためのシステムと方法 | |
| CN111973797A (zh) | 一种骨科用无创植入高黏度胶材料及其制备方法及应用 | |
| US20110177021A1 (en) | Composition for forming a temporary obstruction and method of forming the same | |
| Horák et al. | Poly (2-hydroxyethyl methacrylate) emboli with increased haemostatic effect for correction of haemorrhage of complex origin in endovascular surgery of children |